Rochester: 12:15 pm,Gonda 8-104/Joseph 1-242
Florida: 1:15 pm, MA 3-051S

Headache Conference
F. Michael Cutrer, M.D.
"Genomics of Migraine"

Learning objective:
Describe initial genomic investigations of migraine

Dr. Cutrer (nor spouse/partner) does not have a relevant financial relationship to disclose.  He does intend to discuss an off-label/investigative use of the following commercial product/device: Verapamil

Richard Weinshilboum, M.D.
"Mayo RIGHT 10K Project and Neuro-Pharmacogenomics"

Learning objectives:
Describe the origins and development of pharmacogenomics
Describe the challenges associated with and the infrastructure required for the implementation of pharmacogenomics
Describe the opportunities created for cardiovascular pharmacogenomics by the Mayo RIGHT 10K Project

Dr. Weinshilboum has the following relevant financial relationship to disclose: Stock Shareholder - OneOmeLLC
He does not intend to discuss an off-label/investigative use of a commercial product/device.